Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard E Gendelman

Showing results (1-10 of 354) with videos related to

Pageof 36
Sort By:
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Biomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disordersHoward E Gendelman
Journal of Neurovirology|December 12, 2002
Neural immunity: Friend or foe?Howard E Gendelman
Journal of Leukocyte Biology|November 5, 2003
Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infectionYuri Persidsky, Howard E Gendelman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 13, 2013
The first Insubria autumn school on neuroimmunopharmacology: challenging paradigms beyond boundariesMarco Cosentino, Howard E Gendelman
Current HIV Research|July 18, 2006
Human immunodeficiency virus-mononuclear phagocyte interactions: emerging avenues of biomarker discovery, modes of viral persistence and disease pathogenesisPawel Ciborowski, Howard E Gendelman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 27, 2011
Human immunodeficiency virus type 1 endocytic trafficking through macrophage bridging conduits facilitates spread of infectionIrena Kadiu, Howard E Gendelman
Journal of Neurovirology|December 20, 2002
Murine models for human immunodeficiency virus type 1-associated dementia: the development of new treatment testing paradigmsYuri Persidsky, Howard E Gendelman
Nanomedicine (London, England)|July 4, 2009
NanoART, neuroAIDS and CNS drug deliveryAri Nowacek, Howard E Gendelman
Journal of Proteome Research|May 14, 2011
Macrophage bridging conduit trafficking of HIV-1 through the endoplasmic reticulum and Golgi networkIrena Kadiu, Howard E Gendelman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 25, 2018
HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral EradicationJonathan Herskovitz, Howard E Gendelman
Pageof 36

Showing results (1-10 of 354) with videos related to

Sort By:
Pageof 36
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|November 28, 2007
Biomarkers, laboratory, and animal models for the design and development of adjunctive therapies for HIV-1 dementia and other neuroinflammatory disordersHoward E Gendelman
Journal of Neurovirology|December 12, 2002
Neural immunity: Friend or foe?Howard E Gendelman
Journal of Leukocyte Biology|November 5, 2003
Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infectionYuri Persidsky, Howard E Gendelman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 13, 2013
The first Insubria autumn school on neuroimmunopharmacology: challenging paradigms beyond boundariesMarco Cosentino, Howard E Gendelman
Current HIV Research|July 18, 2006
Human immunodeficiency virus-mononuclear phagocyte interactions: emerging avenues of biomarker discovery, modes of viral persistence and disease pathogenesisPawel Ciborowski, Howard E Gendelman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|July 27, 2011
Human immunodeficiency virus type 1 endocytic trafficking through macrophage bridging conduits facilitates spread of infectionIrena Kadiu, Howard E Gendelman
Journal of Neurovirology|December 20, 2002
Murine models for human immunodeficiency virus type 1-associated dementia: the development of new treatment testing paradigmsYuri Persidsky, Howard E Gendelman
Nanomedicine (London, England)|July 4, 2009
NanoART, neuroAIDS and CNS drug deliveryAri Nowacek, Howard E Gendelman
Journal of Proteome Research|May 14, 2011
Macrophage bridging conduit trafficking of HIV-1 through the endoplasmic reticulum and Golgi networkIrena Kadiu, Howard E Gendelman
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|March 25, 2018
HIV and the Macrophage: From Cell Reservoirs to Drug Delivery to Viral EradicationJonathan Herskovitz, Howard E Gendelman
Pageof 36